Home/Filings/4/0001209191-18-060345
4//SEC Filing

Mayer Eldon C. III 4

Accession 0001209191-18-060345

CIK 0001305253other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 2:26 PM ET

Size

5.1 KB

Accession

0001209191-18-060345

Insider Transaction Report

Form 4
Period: 2018-11-29
Transactions
  • Purchase

    Common Stock

    2018-11-29$10.21/sh+4,000$40,84025,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.00 to $10.37 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1 to this Form 4.

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeother

Related Parties

1
  • filerCIK 0001686952

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 2:26 PM ET
Size
5.1 KB